Hubei Huaqiang High-Tech Co., Ltd. (SHA:688151)
China · Delayed Price · Currency is CNY 25.29
+0.14 (0.56%)
At close: Jul 30, 2025, 2:57 PM CST
Hubei Huaqiang High-Tech Revenue
Hubei Huaqiang High-Tech had revenue of 64.98M CNY in the quarter ending March 31, 2025, a decrease of -46.44%. This brings the company's revenue in the last twelve months to 554.99M, up 10.50% year-over-year. In the year 2024, Hubei Huaqiang High-Tech had annual revenue of 611.35M with 6.74% growth.
Revenue (ttm)
554.99M
Revenue Growth
+10.50%
P/S Ratio
15.39
Revenue / Employee
824.66K
Employees
673
Market Cap
8.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 611.35M | 38.60M | 6.74% |
| Dec 31, 2023 | 572.75M | -12.93M | -2.21% |
| Dec 31, 2022 | 585.68M | -689.56M | -54.07% |
| Dec 31, 2021 | 1.28B | 440.13M | 52.70% |
| Dec 31, 2020 | 835.12M | -812.48M | -49.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 41.48B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |